- Research article
- Open Access
Histopathology-based prognostic score is independent prognostic factor of gastric carcinoma
BMC Cancer volume 14, Article number: 663 (2014)
The aim of our study was to evaluate the histological characteristics and prognosis of gastric cancer.
Clinicopathlogical variables of 932 patients with gastric carcinoma admitted to the Department of Surgical Oncology at the First Hospital of China Medical University were analyzed retrospectively. Different histological characteristics of gastric cancer were summarized and assigned score according to the malignancy defined by WHO classification, the scores were stratified into 4 stage, the prognosis of different stages were analyzed by Kaplan-Meier analysis and cox regression.
Among the 932 patients, 246 (26.39%) had mixed histology type of gastric cancer. Compared to the pure histological type, mixed histological type of gastric cancer was significant associated with tumor size, lymph node metastasis and depth of invasion (all P < 0.05). The 5-year survival rates of advanced and early gastric cancer patients with mixed type were 40.8% and 83.5% respectively, which were lower than those with pure type (50.0% and 95.8%, P < 0.01). Statistically significant difference with stratification of early and advanced stage could be observed between patients with the histological grading score. The data showed that the histological score could be the independent factor of prognosis.
The histological score is an independent factor of gastric cancer, it exerts an excellent ability to classify survival of patients with gastric carcinoma. It also provides a new strategy and parameter for evaluating the biological behavior and prognosis of gastric cancer.
It might be easily thought out that tumor-related factors such as tumor size, lymphatic invasion, and venous invasion could be an indicator for progressive potential of malignant tumors [1–3]. However, except for stage of the tumor, there have not been any criteria using histopathological tumor-related factors to determine the outcome of the patients with gastric carcinoma.
Histopathological type is an important prognosis factor, it is also to determine the extent of surgical resection and formulated the basis for reasonable surgical plan [4, 5]. It plays an important role in prognostic score for a variety of tumors, such as Gleason score for prostate cancer , Child-pugh classification for hepatocellular carcinoma , SBR, WHO score for breast cancer , but the prognostic effect of histopathology has never been reported in gastric cancer. Moreover, there is not any effective way to identify the prognosis of early gastric cancer.
The coexistence of different histological types of gastric cancer determines the the complex characteristics of clinical behavior and prognosis, the mixed histological type accounted for over 25% of all gastric cancer [9, 10]. Since major diagnostic principles are used, the highly heterogeneous histological features of gastric cancer were ignored, tumor biological behavior and prognostic value of minor histological type were coved up . We currently evaluated the prognostic significance of WHO histological classification of gastric cancer with a new histological scoring method, which makes the histopathological variable to be an independent prognostic factor.
In this study, we attempted to evaluate the histological characteristics and establish simple criteria using the results of histopathological tumor-related factors to predict prognosis of patients with gastric carcinoma.
All patients with gastric cancer who underwent surgery at the Department of Surgical Oncology, First Hospital of China Medical University, during January 1980 to December 2006 were entered into a prospectively maintained database. Ethical approval for this research was obtained from the Research Ethics Committee of China Medical University, China. In total, 1077 patients underwent D2 lymphadenectomy and achieved radical (R0) resection for histologically proven gastric carcinoma. Follow-up was complete for the entire study population to June 2005. Among them, 24 died in the postoperative period and 43 were lost to follow-up. Thus, 145 patients were excluded. Of the remaining 932 patients, Median and mean follow-up period were 31 and 54 months (range: 3–313 months), respectively. Patients were treated exclusively by total or subtotal gastrectomy with lymphadenectomy, according to tumor location, adjuvant therapy or postoperative chemotherapy was not administered to any patient. Cancer-specific survival was calculated from the date of primary surgical resection to the date of gastric cancer associated death or to the date of recorded cancer progression. Tumor invasion (T), lymph node involvement (N) and TNM stage were classified according to the 7th UICC/AJCC (2012) staging systems.
According to highly heterogeneous histological features and WHO classification of gastric cancer, we propose the novel histological grading system. Aiming to develop and validate the scoring system, the following statistical computing methodologies were applied in the order indicated:
(1) According to the previous studies of histological differentiation and malignant degree of gastric carcinoma, non-mucinous adenocarcinoma (papillary adenocarcinoma and high, medium and low differentiated tubular adenocarcinoma) were assigned as 1–3 points, respectively. Mucinous adenocarcinoma was assigned as 3 points, signet ring cell carcinoma was assigned as 4 points, undifferentiated carcinoma was assigned as 4 points, a special type of stomach cancer as 4 points (these score still needs further refinement) (Table 1).(2) The total score of gastric carcinoma was summed by the original score of the primary histological type and secondary type of gastric carcinoma. Then the total score was divided by the number of histological types to calculate the final score (The mean of the total score). If it was composed of three or more histological type of gastric tissues, The scores will aggregate all score of histological type, then divideded by the number of histological types to get the final score, as presented in Figure 1. If the carcinoma was composed of a pure histological type (All tumors were constituted by the primary type), the score remains the final score.
Histological grading stage (H Stage) was divided into four groups according to their scores, as follows: H1 (≤2 points), H2 (2–3 points), H3 (3–4 points) and H4 (4–5 points).
Each variable was used as an independent variable in a Cox proportional hazards analysis run using the Kaplan-Meier method. This was done to screen the variables for later inclusion in a multivariable model. To be included in the multivariable analysis, a variable had to be significant at α of 0.1 for the Wald test. This was a test of the null hypothesis that the coefficient for all levels of the variable of interest was equal to zero.
All significant variables of the univariate analysis were included in the first run of a multivariable Cox proportionate hazard regression. In subsequent Cox regressions, significantly different variables in their hazard ratios were remained sequentially based on the z-statistic for the individual levels of each categorical variable. To remain in the final model, a variable had to be significant at α of 0.05 at all levels.
As stated above, the study included 932 patients undergoing gastrectomy for gastric carcinoma from 1980 to 2005. All patients followed until death or for a maximum 313 months. The overall 5-year survival rate was 41.1%. Adjuvant and chemotherapy treatment was rarely applied in this series. The frequencies of patient characteristics and epidemiological results are summarized in Table 2.
Difference of survival reflected by tumor-related factors such as tumor size, tumor depth, lymph node metastasis was shown in Table 3. Compared to the pure histological type, mixed histological type gastric cancer was significant associated with tumor size, lymph node metastasis and depth of invasion (all P < 0.05). All the gastric cancer patients were stratified by advanced and early stage. The 5-year survival rates of advanced and early gastric cancer patients with mixed form were 40.8% and 83.5% respectively, which were lower than those with pure form (50.0% and 95.8%, P < 0.01) ( Figure 2).
Patients stratified by Histological grading of 214 (55.9%), 182 (28.4%), 492 (15.7%) and 44 (28.4%) defined Histological stage I, II, III and IV, respectively. Statistically significant difference with stratification of early and advanced stage could be observed between patients with the histological grading score, respectively. Mixed histological type gastric cancer had worse prognosis in early and advanced stage (Table 2). No significant difference was observed regarding gender and age of the patients. Significant correlation was observed between H grading scores and all of the tumor-related factors (Table 4).The T, N, and TNM stage are the best classification system to classify overall survival of patients with gastric carcinoma, however, there is no effective methodology to evaluate the prognosis of early stage. The 5-year survival rates of gastric cancer patients stratified by histological grading showed there is no superiority compared to T stage and N stage, but the 5-year survival rates of patients with early stage stratified by histological grading was much better than N stage in predicting the prognosis of the early stages, P < 0.01. Significant difference could be observed in survival curves between the early and advanced stage for the same patients, respectively (Figure 3).
The multivariate Cox stepwise proportional hazard model identified Macroscopic type (HR, 1.226, P <0.001), Histological grading (HR, 1.316, P <0.001), T stage (HR, 1.340, P <0.001), N stage (HR, 1.425, P <0.001) as independent predictors of prognosis. In the early gastric cancer, Histological grading (HR, 1.533, P <0.001), Tumor size (HR, 1.412, P <0.001) and N stage (HR, 1.213, P <0.001) as independent predictors of prognosis, histological grading were proved to be the highest HR (Table 5).
Generally, tumor stage composed of depth of tumor, lymph node metastasis, and distant metastasis, might account for the most powerful indicator for the prognosis in the majority of malignant tumors [12–15]. Conventional histopathological variables that have been correlated with prognosis of many malignant neoplasms plays an important role in prognostic score, such as Gleason score of prostate cancer, Child-pugh classification of hepatocellular carcinoma, SBR, WHO score of breast cancer [8, 16, 17].
Nevertheless, for gastric cancer, separated from other cancers, the prognostic value of these factors has not been consistently recognized. It has been reported that there is no relationship between gastric histological type and prognosis, there is no comprehensive pathological conditions or anything about gastric histopathological differentiation in the reflection of gastric cancer staging and prognosis .
However, the practical value of some of histopathological variables is limited due to complexity of gastric histological composition, coexistence of different malignancy subtypes and ambiguity of tumor biological behaviors . Despite their histological variability, usually one of four patterns predominates. The diagnosis is based on the predominant histological pattern . Histologically, most subtypes of carcinoma occur in early gastric cancer in either pure or mixed forms. We performed this study to compare pure or mixed gastric cancer forms of prognosis, The 5-year survival rates of advanced and early gastric cancer patients with mixed form were 40.8% and 83.5% respectively, which were lower than those with pure form (50.0% and 95.8%, P < 0.01).
Proportion of mixed forms gastric cancer patients with N0 stage were significantly lower than with a pure type, patients of mixed type are more likely to lymph node metastasis. Mixed forms were significantly correlated with T stage, so patients were stratified into early and advanced stage, univariate analysis and survival curve showed 5 -year survival of mixed type of early gastric cancer was significantly lower than that that of a pure type, and there was little difference in the advanced stage.
With the histological grading score, there is significantly different between the 5-year survival curves of H Stage, prognosis of early gastric cancer could be identified obviously, which is not reflected in any other current classification. Indeed, statistically significant difference with so strict stratification was observed between patients with H Stage 1–4.
The T, N, or TNM classification system could exert an excellent ability to classify overall survival of patients with gastric carcinoma also in the current study. However, in early gastric cancers, only small mucosal (<4 cm), superficial (>4 cm) and PenA, PenB may have a low incidence of lymph node metastasis with good prognosis after surgery . There is no effective methodology to evaluate the prognosis of early gastric cancer. Our new histological grading provides a new tragedy to identify the prognosis of early gastric cancer.
Of course, TNM classification system could exert an excellent ability to classify survival of patients with gastric carcinoma also in the current study. Therefore, H grading system newly devised as well as TNM classification system could classify the prognosis of patients with gastric carcinoma with a strict stratification. This score system would provide objective information regarding the outcome of patients treated with curative resection for gastric carcinoma.
In conclusion, H Stage that can be utilized in the majority of the institutes would be quite simple criteria to predict prognosis of gastric carcinoma with a strict stratification.
The histological score that we developed in the research exert an excellent ability to classify survival of patients with gastric carcinoma, it could classify the prognosis of patients with gastric carcinoma with a strict stratification. The histological score is an independent factor of gastric cancer. It also provides a new strategy and parameter for evaluating the biological behavior and prognosis of gastric cancer.
Dutta S, Crumley AB, Fullarton GM, Horgan PG, McMillan DC: Comparison of the prognostic value of tumour and patient related factors in patients undergoing potentially curative resection of gastric cancer. Am J Surg. 2012, 204: 294-299. 10.1016/j.amjsurg.2011.10.015.
Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C, Kusunoki M: Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg. 2010, 34: 285-290. 10.1007/s00268-009-0302-1.
Saragoni L, Morgagni P, Gardini A, Marfisi C, Vittimberga G, Garcea D, Scarpi E: Early gastric cancer: diagnosis, staging, and clinical impact. Evaluation of 530 patients. New elements for an updated definition and classification. Gastric Cancer. 2013, 16: 549-554. 10.1007/s10120-013-0233-2.
Becker K, Langer R, Reim D, Novotny A, Meyer zum Buschenfelde C, Engel J, Friess H, Hofler H: Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases. Ann Surg. 2011, 253: 934-939. 10.1097/SLA.0b013e318216f449.
Liu GY, Liu KH, Zhang Y, Wang YZ, Wu XH, Lu YZ, Pan C, Yin P, Liao HF, Su JQ: Alterations of tumor-related genes do not exactly match the histopathological grade in gastric adenocarcinomas. World J Gastroenterol. 2010, 16: 1129-1137. 10.3748/wjg.v16.i9.1129.
Cheney MD, Chen MH, Zhang D, Phillips JG, Loffredo MJ, D'Amico AV: Greatest percentage of involved core length and the risk of death from prostate cancer in men with highest gleason score >/=7. Clin Genitourin Cancer. 2014, 12: 234-240. 10.1016/j.clgc.2014.01.006.
Kim HY, Park JW, Joo J, Kim H, Woo SM, Lee WJ, Kim CM: Worse outcome of sorafenib therapy associated with ascites and Child-Pugh score in advanced hepatocellular carcinoma. J Gastroenterol Hepatol. 2013, 28: 1756-1761. 10.1111/jgh.12310.
Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M: Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer. 1989, 64: 1914-1921. 10.1002/1097-0142(19891101)64:9<1914::AID-CNCR2820640926>3.0.CO;2-G.
Lee JH, Kim JH, Rhee K, Huh CW, Lee YC, Yoon SO, Youn YH, Park H, Lee SI: Undifferentiated early gastric cancer diagnosed as differentiated histology based on forceps biopsy. Pathol Res Pract. 2013, 209: 314-318. 10.1016/j.prp.2013.02.014.
Takizawa K, Ono H, Kakushima N, Tanaka M, Hasuike N, Matsubayashi H, Yamagichi Y, Bando E, Terashima M, Kusafuka K, Nakajima T: Risk of lymph node metastases from intramucosal gastric cancer in relation to histological types: how to manage the mixed histological type for endoscopic submucosal dissection. Gastric Cancer. 2013, 16: 531-536. 10.1007/s10120-012-0220-z.
Song W, Chen CY, Xu JB, Ye JN, Wang L, Chen CQ, Zhang XH, Cai SR, Zhan WH, He YL: Pathological diagnosis is maybe non-essential for special gastric cancer: case reports and review. World J Gastroenterol. 2013, 19: 3904-3910. 10.3748/wjg.v19.i24.3904.
Fisher ER: Prognostic and therapeutic significance of pathological features of breast cancer. NCI Monogr. 1986, 1: 29-34.
Toki F, Takahashi A, Aihara R, Ogata K, Ando H, Ohno T, Mochiki E, Kuwano H: Relationship between clinicopathological features and mucin phenotypes of advanced gastric adenocarcinoma. World J Gastroenterol. 2010, 16: 2764-2770. 10.3748/wjg.v16.i22.2764.
Yokota T, Ishiyama S, Saito T, Teshima S, Narushima Y, Murata K, Iwamoto K, Yashima R, Yamauchi H, Kikuchi S: Lymph node metastasis as a significant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol. 2004, 39: 380-384. 10.1080/00365520310008629.
Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H: Significant prognostic factors in patients with early gastric cancer. Int Surg. 2000, 85: 286-290.
Babaian RJ, Grunow WA: Reliability of Gleason grading system in comparing prostate biopsies with total prostatectomy specimens. Urology. 1985, 25: 564-567. 10.1016/0090-4295(85)90280-8.
Albers I, Hartmann H, Bircher J, Creutzfeldt W: Superiority of the Child-Pugh classification to quantitative liver function tests for assessing prognosis of liver cirrhosis. Scand J Gastroenterol. 1989, 24: 269-276. 10.3109/00365528909093045.
Davessar K, Pezzullo JC, Kessimian N, Hale JH, Jauregui HO: Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum Pathol. 1990, 21: 325-332. 10.1016/0046-8177(90)90234-V.
Grundmann E, Schlake W: Histological classification of gastric cancer from initial to advanced stages. Pathol Res Pract. 1982, 173: 260-274. 10.1016/S0344-0338(82)80088-5.
Inoshita N, Yanagisawa A, Arai T, Kitagawa T, Hirokawa K, Kato Y: Pathological characteristics of gastric carcinomas in the very old. Jpn J Cancer Res. 1998, 89: 1087-1092. 10.1111/j.1349-7006.1998.tb00501.x.
Flejou JF: [WHO Classification of digestive tumors: the fourth edition]. Ann Pathol. 2011, 31: S27-S31. 10.1016/j.annpat.2011.08.001.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2407/14/663/prepub
This work was supported by grants from the National Natural Science Foundation of China (81302129) and General Project of Liaoning Provincial Education Department (L2013291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
The authors declare that they have no competing interests.
HX conceived and designed the study; ZZ, ZS and JW collected and analyzed the data; ZZ and XS wrote the manuscript; ZW and XZ provided critical revisions that are important for the intellectual content; HX approved the final version of the manuscript. All authors read and approved the final manuscript.
Zhi Zhu, Xuren Sun contributed equally to this work.
About this article
Cite this article
Zhu, Z., Sun, X., Wang, J. et al. Histopathology-based prognostic score is independent prognostic factor of gastric carcinoma. BMC Cancer 14, 663 (2014). https://doi.org/10.1186/1471-2407-14-663
- Gastric cancer
- Histological type
- Tumor differentiation